By Casey Ross
Aug. 23, 2024
Chief Investigative Reporter, Data & Technology
The use of artificial intelligence in hospitals is ramping up so fast — and with such little transparency — that it is impossible to track how any given product is impacting the cost or quality of care. Whether AI is monitored at all is entirely up to individual health systems.
“Everybody is doing this differently, and many health systems are not doing it,” said Michael Pencina, chief data scientist at Duke Health. The lack of systematic monitoring of AI in medicine creates safety and financial risks, he said, because poorly performing products can easily escape scrutiny.
advertisement
Pencina is among those proposing to fill the void with a new approach — a national registry of AI tools that would list where products are being used and provide background information about their development and performance. It is not an entirely novel idea.
STAT+ Exclusive Story
Already have an account? Log in
Already have an account? Log in
Monthly
$39
Totals $468 per year
$39/month Get StartedTotals $468 per year
Starter
$20
for 3 months, then $399/year
$20 for 3 months Get StartedThen $399/year
Annual
$399
Save 15%
$399/year Get StartedSave 15%
11+ Users
Custom
Savings start at 25%!
Request A Quote Request A QuoteSavings start at 25%!
2-10 Users
$300
Annually per user
$300/year Get Started$300 Annually per user
View All PlansTo read the rest of this story subscribe to STAT+.
Subscribe Log In Artificial intelligence, health tech, Policy, STAT+ Submit a correction requestReprintsCasey Ross
Chief Investigative Reporter, Data & Technology
Casey Ross covers the use of artificial intelligence in medicine and its underlying questions of safety, fairness, and privacy.
Tech is transforming health care and life sciences. Our original reporting is here to keep you ahead of the curve.